Zepbound — Cigna

Weight management in adults with obesity or overweight with comorbid conditions

Reauthorization criteria

Patient is ≥ 18 years of age; AND
Patient meets ONE of the following (a or b):
a) At baseline, patient had a BMI ≥ 30 kg/m2; OR
b) Patient meets BOTH of the following [(1) and (2)]:
(1) At baseline, patient had a BMI ≥ 27 kg/m2; AND
(2) At baseline, patient had, or patient currently has, at least ONE of the following weight-related comorbidities: hypertension, type 2 diabetes, dyslipidemia, obstructive sleep apnea, cardiovascular disease, knee osteoarthritis, asthma, chronic obstructive pulmonary disease, metabolic dysfunction-associated steatotic liver disease/non-alcoholic fatty liver disease, polycystic ovarian syndrome, or coronary artery disease; AND
Patient has lost ≥ 5% of baseline body weight; AND
The medication will be used concomitantly with behavioral modification and a reduced-calorie diet.

1 year